Therapeutic effect of proton pump inhibitor (Omeprazole) on homogenous leukoplakia with clinico-fractal analysis: A pilot study
Background: Oral leukoplakia is a white patch or plaque that cannot be characterized clinically or pathologically as any other disease and is not associated with any physical or chemical causative agent except the use of tobacco. The prevalence of leukoplakia in India varies from 0.2% to 4.9% with v...
Main Authors: | Nivethitha Nagarajan, S Jayachandran |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Journal of Indian Academy of Oral Medicine and Radiology |
Subjects: | |
Online Access: | http://www.jiaomr.in/article.asp?issn=0972-1363;year=2020;volume=32;issue=4;spage=323;epage=329;aulast=Nagarajan |
Similar Items
-
Use of the Fractal Dimension to Differentiate Epithelium and Connective Tissue in Oral Leukoplakias
by: Yolanda Guerrero-Sánchez, et al.
Published: (2022-05-01) -
Clopidogrel and proton pump inhibitor (PPI) interaction: separate intake and a non-omeprazole PPI the solution?
by: Kenngott S, et al.
Published: (2010-05-01) -
AN LC- MS/MS METHOD FOR THE DETERMINATION OF OMEPRAZOLE ON PROTON PUMP INHIBITOR IN HUMAN PLASMA
by: T. Sudha, et al.
Published: (2016-04-01) -
Proliferative verrucus leukoplakia: A case series
by: Mainak Datta, et al.
Published: (2022-01-01) -
The Role of Vitamin A, Vitamin C and Vitamin E for Chemoprevention of Oral Leukoplakia
by: Mohidul Islam, et al.
Published: (2023-10-01)